脂蛋白(a)与淋巴细胞比值联合C反应蛋白与高密度脂蛋白胆固醇比值对冠心病及其严重程度的预测价值

Predictive value of the ratio of lipoprotein(a) to lymphocytes combined with the ratio of C-reactive protein to high-density lipoprotein cholesterol for coronary heart disease and its severity

  • 摘要:
    目的 探讨脂蛋白(a)Lp(a)与淋巴细胞比值Lp(a)/LYM联合C反应蛋白(CRP)与高密度脂蛋白胆固醇(HDL-C)比值(CHR)对冠心病及其严重程度的预测价值。
    方法 回顾性选取接受冠状动脉造影检查的患者为研究对象, 按纳入与排除标准筛选,最终纳入冠心病组291例和非冠心病组155例。比较2组患者的临床资料,通过单因素和多因素Logistic回归分析筛选冠心病的独立影响因素。依据Gensini评分,将冠心病组患者分为高Gensini评分组、中Gensini评分组和低Gensini评分组,比较3组临床资料,并分析Lp(a)/LYM、CHR与Gensini评分的相关性。绘制受试者工作特征(ROC)曲线,分析Lp(a)/LYM、CHR对冠心病及冠状动脉重度病变的预测效能。
    结果 冠心病组与非冠心病组在性别、年龄、吸烟史、糖尿病、卒中、高血压、中性粒细胞计数、淋巴细胞计数、单核细胞计数、CRP、HDL-C、载脂蛋白A1、Lp(a)、Lp(a)/LYM和CHR方面比较,差异均有统计学意义(P < 0.05); 多因素Logistic回归分析显示,年龄、吸烟史、糖尿病、高血压、Lp(a)/LYM和CHR是冠心病的独立影响因素(P < 0.05); ROC曲线显示,Lp(a)/LYM、CHR单独预测冠心病的曲线下面积(AUC)分别为0.704、0.864, 二者联合预测的AUC为0.875, 预测效能显著高于单独预测(P < 0.001)。3组冠心病患者在年龄、住院时间、入院时心率、中性粒细胞计数、淋巴细胞计数、CRP、HDL-C、Lp(a)、Lp(a)/LYM和CHR方面比较,差异均有统计学意义(P < 0.05); Spearman相关分析结果显示,冠心病患者Lp(a)/LYM、CHR均与Gensini评分呈正相关(r=0.347、0.389, P < 0.001); ROC曲线显示,Lp(a)/LYM、CHR单独预测冠状动脉重度病变的AUC分别为0.706、0.712, 二者联合预测的AUC为0.779, 预测效能显著高于单独预测(P < 0.001)。
    结论 Lp(a)/LYM和CHR均为冠心病的独立影响因素,二者联合可较好地预测冠心病及其严重程度。

     

    Abstract:
    Objective To explore the predictive value of the ratio of lipoprotein(a) Lp(a) to lymphocytes Lp(a)/LYM combined with the ratio of C-reactive protein (CRP) to high-density lipoprotein cholesterol (HDL-C) (CHR) for coronary heart disease and its severity.
    Methods Patients who underwent coronary angiography were retrospectively selected as the study subjects. According to the inclusion and exclusion criteria, 291 cases were finally included in coronary heart disease group and 155 cases in non-coronary heart disease group. The clinical data of the two groups were compared, and the independent influencing factors of coronary heart disease were screened through univariate and multivariate logistic regression analysis. Based on the Gensini score, patients in the coronary heart disease group were divided into high, medium, and low Gensini score groups. The clinical data of the three groups were compared, and the correlations between Lp(a)/LYM, CHR, and the Gensini score were analyzed. Receiver operating characteristic (ROC) curves were plotted to analyze the predictive efficacy of Lp(a)/LYM and CHR for coronary heart disease and severe coronary artery lesions.
    Results There were statistically significant differences between the coronary heart disease group and the non-coronary heart disease group in terms of gender, age, smoking history, diabetes, stroke, hypertension, neutrophil count, lymphocyte count, monocyte count, CRP, HDL-C, apolipoprotein A1, Lp(a), Lp(a)/LYM, and CHR (P < 0.05). Multivariate logistic regression analysis showed that age, smoking history, diabetes, hypertension, Lp(a)/LYM, and CHR were independent influencing factors for coronary heart disease (P < 0.05). The ROC curve showed that the areas under the curve (AUC) for Lp(a)/LYM and CHR in predicting coronary heart disease alone were 0.704 and 0.864, respectively, and the AUC for their combined prediction was 0.875, with a significantly higher predictive efficacy compared to individual prediction (P < 0.001). There were statistically significant differences among the three groups of coronary heart disease patients in terms of age, length of hospital stay, heart rate on admission, neutrophil count, lymphocyte count, CRP, HDL-C, Lp(a), Lp(a)/LYM, and CHR (P < 0.05). Spearman correlation analysis showed that Lp(a)/LYM and CHR in patients with coronary heart disease were positively correlated with the Gensini score (r=0.347, 0.389, P < 0.001). The ROC curve showed that the AUCs for Lp(a)/LYM and CHR in predicting severe coronary artery lesions alone were 0.706 and 0.712, respectively, and the AUC for their combined prediction was 0.779, with a significantly higher predictive efficacy compared to individual predictions (P < 0.001).
    Conclusion Both Lp(a)/LYM and CHR are independent influencing factors for coronary heart disease, and their combination can better predict coronary heart disease and its severity.

     

/

返回文章
返回